Tranexamic Acid Nardia 500 mg/5 ml
Tranexamic Acid Nardia 500 mg/5 ml is a medicine authorised by Swissmedic under authorisation number 70581. The authorisation holder is Nardia Pharmaceuticals SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 February 2026 and the authorisation is limited until 18 February 2031. ATC code B02AA02 places the medicine in the group Antihemorrhagics.
| Authorisation number | 70581 |
|---|---|
| Name | Tranexamic Acid Nardia 500 mg/5 ml |
| Full name | Tranexamic Acid Nardia 500 mg/5 ml, soluzione iniettabile |
| Authorisation holder | Nardia Pharmaceuticals SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B02AA02 |
| First authorisation | 19 February 2026 |
| Authorisation validity | 18 February 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tranexamic Acid Nardia 500 mg/5 ml, soluzione iniettabile | B | 19 February 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 | Ampulle(n) | B02AA02 | 06.06.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Tranexamic Acid Nardia 500 mg/5 ml authorised in Switzerland?
Yes. Tranexamic Acid Nardia 500 mg/5 ml is authorised by Swissmedic under authorisation number 70581, data as of 01 September 2026. The authorisation is limited until 18 February 2031.
Which dispensing category does Tranexamic Acid Nardia 500 mg/5 ml have?
Tranexamic Acid Nardia 500 mg/5 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Tranexamic Acid Nardia 500 mg/5 ml?
The authorisation holder is Nardia Pharmaceuticals SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.